References
ACCF/AHA consensus conference report on professionalism and ethics. Presented in Bethesda, Maryland, June 2-3, 2004. Circulation 2004;110:2506–2549.
BHAT Study Group. the beta-blocker heart attack trial. JAMA 1981;246:2073–2074.
CAST Investigators. Preliminary Report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. New Engl J Med 1989;321:406–412.
AVID Investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-faal ventricular arrhythmias. New Engl J Med 1997;337:15761–15783.
AFFIRM Investigators. A comparison of rate control and rhythm control in patients with atrial fibrillation. New Engl J Med 2002;347:1825–1833.
Moore TJ. Deadly Medicine: Why Tens of Thousands of Heart Patients Died in America’s Worst Drug Disaster. New York. Simon & Schuster, 1995.
Anderson JL, Pratt CM, Waldo AL, Karagounis LA. Impact of the food and drug administration approval of flecainide and encainide on coronary artery disease mortality: putting “Deadly Medicine” to the test. Am J Cardiol 1997;79:43–47.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wyse, D.G. Conflict of Interest—Draining the Swamp Means Confronting Alligators. J Interv Card Electrophysiol 13, 5–7 (2005). https://doi.org/10.1007/s10840-005-0987-5
Issue Date:
DOI: https://doi.org/10.1007/s10840-005-0987-5